{"title":"Non-insulin Medications for the Management of Type 2 Diabetes.","authors":"Marla J Hayes","doi":"10.1097/NHH.0000000000001232","DOIUrl":null,"url":null,"abstract":"<p><p>Type 2 diabetes (T2D) is predicted to affect 366 million people over the age of 65 years by the year 2030. As the understanding of the core defects associated with T2D advanced, researchers recognized management should target multiple defects in glucose metabolism. As a result, efforts to manage T2D focus on developing new drug therapies aimed at addressing each of the identified metabolic defects. Optimal treatment of T2D is necessary to decrease the risk for coronary heart disease, stroke, and vascular diseases. This article discusses non-insulin pharmacologic treatments for T2D that are guided by glycemic efficacy, safety profiles, effects on weight and hypoglycemia risk, tolerability, patient comorbidities, route of administration, patient preference, and cost.</p>","PeriodicalId":37842,"journal":{"name":"Home healthcare now","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Home healthcare now","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/NHH.0000000000001232","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
Abstract
Type 2 diabetes (T2D) is predicted to affect 366 million people over the age of 65 years by the year 2030. As the understanding of the core defects associated with T2D advanced, researchers recognized management should target multiple defects in glucose metabolism. As a result, efforts to manage T2D focus on developing new drug therapies aimed at addressing each of the identified metabolic defects. Optimal treatment of T2D is necessary to decrease the risk for coronary heart disease, stroke, and vascular diseases. This article discusses non-insulin pharmacologic treatments for T2D that are guided by glycemic efficacy, safety profiles, effects on weight and hypoglycemia risk, tolerability, patient comorbidities, route of administration, patient preference, and cost.
期刊介绍：
Home Healthcare Now is the professional, contemporary journal serving the educational and communication needs of home care and hospice nurses. The journal is highly interactive and timely, focusing on the multidimensional, interdisciplinary and specialty practice areas of home care nursing. Clinical, operational, and educational home care nursing issues are the core of the publication; plentiful columns and features focus on practical, up-to-date approaches to everyday situations, as well as analysis and interpretation of how healthcare trends affect the home care nurse''s practice.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
